- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.08. | Functional Brands: Gross Margin Jumps 710 Basis Points Despite Volatile Listing | 1 | pulse2.com | ||
| 17.08. | Functional Brands Inc. GAAP EPS of -$0.06, revenue of $1.87M | 1 | Seeking Alpha | ||
| 17.08. | Functional Brands Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.07. | NSE - Functional Brands Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 01.07. | Functional Brands Inc. - 8-K, Current Report | - | SEC Filings | ||
| 15.06. | Functional Brands faces Nasdaq delisting after stock falls below $0.10 | 2 | Investing.com | ||
| 15.06. | Functional Brands Inc.: Functional Brands Inc. Receives Nasdaq Staff Delisting Determination | 375 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 15, 2026) - Functional Brands Inc. (NASDAQ: MEHA) (the "Company"), a leading innovator in wellness and performance products, announced today that on June... ► Artikel lesen | |
| FUNCTIONAL BRANDS Aktie jetzt für 0€ handeln | |||||
| 15.06. | Functional Brands Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 05.06. | Functional Brands Inc.: Functional Brands Inc. Announces Active Interest from Multiple Strategic Partners to Fund BullionFX | Alchemy Commercialization Following Pending Acquisition of the BFX Assets | 730 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 5, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("MEHA" or the "Company") today announced advanced discussions with multiple strategic financial parties... ► Artikel lesen | |
| 04.06. | Functional Brands Inc.: Functional Brands Inc. Enters BullionFX | Alchemy Acquisition From a Position of Improving Financial Strength | 606 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 4, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a U.S.-domiciled Nasdaq issuer, which is party to a binding agreement to acquire the assets of BullionFX... ► Artikel lesen | |
| 03.06. | Functional Brands shareholders approve reverse stock split | 4 | Investing.com | ||
| 03.06. | Functional Brands Inc.: Functional Brands Inc. Clears Barrier to $142.9 Million BullionFX | Alchemy Acquisition | 486 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - June 3, 2026) - Functional Brands Inc. (NASDAQ: MEHA), announced that shareholders have voted to authorize the reverse stock split, removing an obstacle between... ► Artikel lesen | |
| 28.05. | Functional Brands Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 28.05. | Functional Brands Inc.: Functional Brands Announces Adjournment of Special Meeting of Stockholders | 532 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 27, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that the Company's Special... ► Artikel lesen | |
| 22.05. | Functional Brands to acquire BullionFX for $142.9M | 3 | Seeking Alpha | ||
| 22.05. | Functional Brands kündigt Übernahme von BullionFX-Assets im Wert von 142,9 Mio. US-Dollar an | 19 | Investing.com Deutsch | ||
| 22.05. | Functional Brands to acquire BullionFX assets for $142.9M | 2 | Investing.com | ||
| 22.05. | Functional Brands Inc.: Functional Brands Enters into Agreement to Acquire Alchemy, a Gold-Backed Blockchain Settlement Platform, in a $142.9 Million Transaction | 723 | Newsfile | Lake Oswego, Oregon--(Newsfile Corp. - May 22, 2026) - Functional Brands Inc. (NASDAQ: MEHA) ("Functional Brands" or the "Company") today announced the execution of a definitive agreement for the... ► Artikel lesen | |
| 19.05. | Functional Brands informiert Aktionäre über mögliche Übernahme von BullionFX-Vermögenswerten | 1 | Investing.com Deutsch | ||
| 18.05. | Functional Brands Inc. GAAP EPS of -$0.36, revenue of $1.65M | 1 | Seeking Alpha |
1 2 3 Weiter >>
51 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,980 | +0,55 % | Bayers Sevabertinib erhält FDA-Zulassung für bestimmte Form von Lungenkrebs | DJ Bayers Sevabertinib erhält FDA-Zulassung für bestimmte Form von Lungenkrebs
DOW JONES--Bayers Wirkstoff Sevabertinib hat von der US-Arzneimittelbehörde FDA eine Zulassung zur Behandlung einer... ► Artikel lesen | |
| DATAMEDS AI | 6,070 | 0,00 % | DataMEDS AI, Inc.: DataMEDS, AI. Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from Axe Compute | Acquisition Provides Operational Capital to Drive Health Lives Here Campaign and Expand Services into Cancer Management PITTSBURGH, PA / ACCESS Newswire / September 15, 2026 / DataMEDS AI, Inc. (NASDAQ:MEDS)... ► Artikel lesen | |
| MERCK KGAA | 131,70 | +0,61 % | MilliporeSigma: Biopharma Circular Systems Will Move Beyond Park Benches | Jeffrey Whitford, Vice President of Sustainability and Social Business Innovation, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, GermanyOriginally published by... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 56,35 | 0,00 % | Biotech Stocks At 52-Week Highs - Eton Pharmaceuticals +44%, DexCom, Oruka Therapeutics, Concentra Group Holdings Parent, AtaiBeckley | INDIANAPOLIS (dpa-AFX) - The following biotech stocks reached 52-week highs on August 14, 2026, following positive quarterly reports or an announced upcoming acquisition. Eton Pharmaceuticals... ► Artikel lesen | |
| LB PHARMACEUTICALS | 42,570 | 0,00 % | LB Pharmaceuticals Appoints Susan Kozauer As CMO | ||
| NOVO NORDISK | 36,445 | 0,00 % | Pharmaaktie: Novo Nordisk auf Juni-Tief nach Abstufung | Morgan Stanley hat Novo Nordisk auf "Underweight" abgestuft und verweist auf den drohenden Patentauslauf von Semaglutid als zentrales Risiko. Die Aktie fiel daraufhin auf das tiefste Niveau seit Juni.... ► Artikel lesen | |
| GENERATE BIOMEDICINES | 15,680 | 0,00 % | Generate Biomedicines auf der H.C. Wainwright Konferenz: Plattform-Strategie im Fokus | ||
| SCHOTT PHARMA | 23,050 | -0,43 % | JPMORGAN stuft Schott Pharma auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Bewertung von Schott Pharma beim Kursziel von 27,10 Euro mit "Overweight" aufgenommen. Der Spezialist für Aufbewahrung und Verabreichung injizierbarer... ► Artikel lesen | |
| OMNIAB | 4,350 | 0,00 % | Veraxa Biotech AG: VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb | VXA-222 advances into next phase at VERAXAZURICH, SWITZERLAND, July 27, 2026 --
VERAXA Biotech AG (NASDAQ: VRXA; "VERAXA" or the "Company"), an emerging leader in designing novel cancer therapies... ► Artikel lesen | |
| APNIMED | 27,120 | +0,11 % | Apnimed, Inc.: Apnimed Reports Second Quarter 2026 Financial Results and Provides Corporate Update | U.S. Food and Drug Administration ("FDA") Accepted the NDA for AD109, with a proposed proprietary name Oxnimbi- and assigned a PDUFA target action date of February 28,- 2027 If approved, Oxnimbi... ► Artikel lesen | |
| PFIZER | 23,870 | -0,33 % | IP Group: NAV Reaches £1 Billion As Pfizer Obesity Royalty Value Rises To £152 Million | ||
| NOVARTIS | 121,22 | -0,13 % | BERENBERG stuft NOVARTIS AG auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Novartis von 120 auf 105 Franken gesenkt, aber die Einstufung auf "Hold" belassen. Die Schweizer hätten nun binnen weniger... ► Artikel lesen | |
| MEDICINOVA | 2,520 | 0,00 % | Biotech Stocks At 52-Week Highs - MediciNova +8%, Revvity +8%, 10x Genomics +6%, Telix Pharmaceuticals +9%, Schrodinger Inc. +12% | CANBERA (dpa-AFX) - The following biotech stocks reached a 52-week high on September 15, 2026, driven by the gain on certain clinical or financial results.MediciNova Inc. (MNOV)MediciNova functions... ► Artikel lesen | |
| KARDIGAN | 17,270 | -0,23 % | Citi's U.S. Consumer Cards Business To Buy Kard Financial For Undisclosed Terms | WASHINGTON (dpa-AFX) - Banking major Citigroup Inc. (C) announced late Thursday that its U.S. Consumer Cards business has agreed to acquire Kard Financial, a commerce media and rewards platform.... ► Artikel lesen | |
| DERMAPHARM | 38,550 | +1,98 % | JEFFERIES stuft Dermapharm auf 'Hold' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Dermapharm nach einem Treffen mit dem Finanzchef Christof Dreibholz mit einem Kursziel von 44 Euro auf "Hold" belassen.... ► Artikel lesen |
Das Unternehmen FUNCTIONAL BRANDS INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell -2,13 % bei einem Aktienkurs von 0,018 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FUNCTIONAL BRANDS INC finden Sie auf Wallstreet Online.